Breast Cancer
Latest News in Breast Cancer
July 5, 2022
Enhertu Improves Survival for Metastatic “HER2-Low” Breast Cancer – NCI Cancer Bulletin
June 5, 2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer – nejm.org
3036 Active Breast Cancer Clinical Trials
3036 Active Breast Cancer Clinical Trials
As of November 12, 2024
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS